Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas.

Cancer medicine - 1 Jul 2023

Torkildsen Cecilie Fredvik, Thomsen Liv Cecilie Vestrheim, Sande Ragnar Kvie, Krakstad Camilla, Stefansson Ingunn, Lamark Eva Karin, Knappskog Stian, Bjørge Line

Abstract excerpt

BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the deadliest ovarian cancer subtype, and survival relates to initial cytoreductive surgical treatment. The existing tools for surgical outcome prediction remain inadequate for anticipating the outcomes of the complex relationship between tumour biology, clinical phenotypes, co-morbidity and surgical skills. In this genotype-phenotype association study,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 37191035
DOI: 10.1002/cam4.6085
PMCID: PMC10358208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas.PMID 37191035Read ↗

Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratificationSemantic proximity Read ↗

The Changing View of High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Integrated genomic and histopathological analysis of low grade serous ovarian carcinoma identifies clinically distinct disease subtypesSemantic proximity Read ↗

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategiesSemantic proximity Read ↗

Efficient molecular subtype classification of high‐grade serous ovarian cancerSemantic proximity Read ↗

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High Grade Serous Ovarian CancerSemantic proximity Read ↗

Genetic and molecular changes in ovarian cancerSemantic proximity Read ↗

The molecular prognostic score , a classifier for risk stratification of high-grade serous ovarian cancerSemantic proximity Read ↗

Molecular characteristics and clinical behaviour of epithelial ovarian cancers.Semantic proximity Read ↗

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.Semantic proximity Read ↗

Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.